Immediate Impact
52 standout
Citing Papers
Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives
2025 Standout
Breast cancer: pathogenesis and treatments
2025 Standout
Works of Danmei Pang being referenced
Multicenter phase II study of apatinib, a novel VEGFR inhibitor in heavily pretreated patients with metastatic triple-negative breast cancer
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Danmei Pang | 195 | 116 | 151 | 16 | 354 | |
| Chester Kao | 157 | 107 | 153 | 19 | 316 | |
| M. D’Arcangelo | 194 | 118 | 190 | 30 | 344 | |
| Carolien Boeckx | 221 | 153 | 108 | 15 | 366 | |
| Laura Demurtas | 228 | 107 | 81 | 20 | 348 | |
| Peter Houghton | 148 | 167 | 163 | 20 | 391 | |
| Davide Bosso | 128 | 128 | 162 | 18 | 348 | |
| Laura Palmeri | 281 | 83 | 130 | 20 | 382 | |
| Alexander B. Sibley | 164 | 113 | 78 | 26 | 370 | |
| Nishi Kothari | 233 | 92 | 155 | 29 | 363 | |
| Bérengère Dadone | 119 | 178 | 169 | 17 | 372 |
All Works
Login with ORCID to disown or claim papers
Loading papers...